cyclosporine has been researched along with Keratoconjunctivitis in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (12.77) | 18.2507 |
2000's | 16 (34.04) | 29.6817 |
2010's | 18 (38.30) | 24.3611 |
2020's | 7 (14.89) | 2.80 |
Authors | Studies |
---|---|
Beisse, F; Biermann, J; Bosche, F; Eter, N | 1 |
Han, G; Hawkins, BS; Kuo, IC; Leslie, L; Liu, SH; Ng, SM; Ren, M | 1 |
Calder, V; Dahlmann-Noor, AH; Hingorani, M; Muthusamy, K; Roberts, C | 2 |
Aydamirov, AS; Erdem, E; Harbiyeli, II; Ozturk, G; Yagmur, M; Yarkin, F | 1 |
Chargui, S; Fekih, O; Malek, I; Nacef, L; Zghal, I; Zgolli, HM | 1 |
Arici, C; Mergen, B | 1 |
Andreani, M; Artesani, MC; Buzzonetti, L; Esposito, M; Fiocchi, A; Locatelli, F; Mennini, M | 1 |
Álvarez Martín, T; Ferrando Piqueres, R; Pitarch Bort, G; Raga Jiménez, C | 1 |
Akpek, EK; Stern, M; Utine, CA | 1 |
Alaghband, P; Hutchinson, C; Oworu, O | 1 |
Chu, DS; Fang, C; Kim, E; Kim, JS; Kolomeyer, AM; Nayak, NV; Ragam, A | 1 |
Chu, DS; Fang, C; Kim, ES; Kim, JS; Kolomeyer, AM; Nayak, NV; Ragam, A | 1 |
Birnbaum, F; Pleyer, U | 1 |
Altınörs, DD; Asena, L; Burcu, A; Çolak, M; Ercan, E; Şıngar Özdemir, E | 1 |
Ebihara, N; Fujishima, H; Fukushima, A; Kumagai, N; Nakagawa, Y; Nanba, K; Ohashi, Y; Okamoto, S; Shoji, J; Takamura, E; Uchio, E | 1 |
Mircheff, AK; Samant, DM; Schechter, JE; Selvam, S; Song, SW; Stevenson, D; Thomas, PB; Trousdale, MD; Wang, Y; Yiu, SC; Zhu, Z | 1 |
Auw-Hädrich, C; Reinhard, T | 1 |
Broadfoot, AJ; Fernando, SL | 1 |
Bahar, I; Levinger, E; Sansanayudh, W; Slomovic, A; Slomovic, AR | 1 |
Bielory, B; Bielory, L | 1 |
Calder, V; Dart, JK; Guglielmetti, S | 1 |
Holsclaw, DS; Jeng, BH | 1 |
Gesser, C; Kaulfers, PM; Loderstädt, U; Meyer-Rüsenberg, B; Richard, G | 1 |
Arora, R; Goyal, JL; Gupta, D; Jain, P | 1 |
Comez, A; Coskun, E; Erbagci, I; Gurler, B; Kaydu, E; Okumus, S; Tatar, MG; Yayuspayi, R | 1 |
Fernández Buenaga, R; González-López, JJ; López-Alcalde, J; Morcillo Laiz, R; Rebolleda Fernández, G | 1 |
Choi, DS; Djalilian, A | 1 |
Donnenfeld, ED; Doshi-Carnevale, S; Kornstein, HS; Perry, HD | 1 |
Mootha, VV; Rhee, MK | 1 |
Bungay, PM; Csaky, KG; de Monasterio, F; Dunn, JP; Gilger, BC; Kim, H; Lee, SS; Lutz, RJ; Robinson, MR; Tansey, G; Tremblay, M; Yuan, P | 1 |
Akpek, EK; Tatlipinar, S | 1 |
Abitbol, O; Doan, S; Duong, MH; Gabison, E; Gatinel, D; Hoang-Xuan, T | 1 |
Armenio, L; Bellizzi, G; Bellizzi, M; Brunetti, L; Cardinale, F; Fanelli, P; Procoli, U; Rizzo, G; Spadavecchia, L; Tesse, R | 1 |
Bozkurt, B; Irkec, M; Sahin, A | 1 |
Neiberg, MN; Sowka, J | 1 |
Birnbaum, F; Böhringer, D; Reinhard, T | 1 |
Barnett, KC; Read, RA; Sansom, J | 1 |
Borghesan, F; Faggian, D; Leonardi, A; Plebani, M; Secchi, A | 1 |
Reinhard, T; Sundmacher, R | 2 |
Köstlin, R | 1 |
Meller, D; Tseng, SC | 1 |
Godehardt, E; Pfahl, HG; Reinhard, T; Sundmacher, R | 1 |
Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R | 2 |
Nussenblatt, R | 1 |
11 review(s) available for cyclosporine and Keratoconjunctivitis
Article | Year |
---|---|
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctivitis; Conjunctivitis, Viral; Cyclosporine; Dexamethasone; Female; Fluorometholone; Ganciclovir; Humans; Keratoconjunctivitis; Levofloxacin; Lubricant Eye Drops; Male; Middle Aged; Povidone-Iodine; Tacrolimus; Trifluridine; Young Adult | 2022 |
Topical cyclosporine A 1 mg/ml for atopic keratoconjunctivitis: Five-year case series of 99 children and young people.
Topics: Administration, Topical; Adolescent; Child; Cohort Studies; Conjunctivitis, Allergic; Cyclosporine; Exanthema; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Ophthalmic Solutions; Treatment Outcome | 2023 |
Vernal keratoconjunctivitis in twins: case report and literature review.
Topics: Administration, Topical; Child; Cyclosporine; Genetic Predisposition to Disease; Haplotypes; HLA Antigens; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Pedigree; Twins, Monozygotic | 2021 |
[Treatment of chronic blepharokeratoconjunctivitis with local calcineurin inhibitors].
Topics: Administration, Topical; Blepharitis; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Tacrolimus | 2009 |
Atopic dermatitis and keratoconjunctivitis.
Topics: Adrenal Cortex Hormones; Animals; Blepharitis; Cyclosporine; Dermatitis, Atopic; Humans; Immunomodulation; Keratoconjunctivitis; Risk Factors; Tacrolimus | 2010 |
Atopic keratoconjunctivitis and atopic dermatitis.
Topics: Basophils; Conjunctivitis, Allergic; Cyclosporine; Cytokines; Dermatitis, Atopic; Drug Resistance; Eosinophils; Epithelial Cells; Humans; Interleukin-33; Interleukins; Keratoconjunctivitis; Tacrolimus; Thymic Stromal Lymphopoietin | 2010 |
Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.
Topics: Adenovirus Infections, Human; Chronic Disease; Cross-Sectional Studies; Cyclosporine; Disease Notification; Disinfection; Epidemics; Germany; Hand Disinfection; Humans; Immunosuppressive Agents; Incidence; Keratoconjunctivitis; Ophthalmic Solutions; Randomized Controlled Trials as Topic | 2011 |
Topical cyclosporine for atopic keratoconjunctivitis.
Topics: Administration, Topical; Cyclosporine; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Randomized Controlled Trials as Topic | 2012 |
Bilateral keratoconjunctivitis associated with lichen planus.
Topics: Administration, Oral; Administration, Topical; Adult; Amnion; Cyclosporine; Humans; Keratoconjunctivitis; Lichen Planus; Male; Prednisone | 2004 |
Topical ciclosporin in the treatment of ocular surface disorders.
Topics: Conjunctivitis; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Humans; Immunosuppressive Agents; Keratitis; Keratoconjunctivitis; Lichen Planus; Ophthalmic Solutions | 2005 |
The expanding use of immunosuppression in the treatment of non-infectious ocular disease.
Topics: Bromocriptine; Corneal Transplantation; Cyclosporine; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Humans; Immunosuppression Therapy; Keratoconjunctivitis; Prednisone; Uveitis | 1992 |
5 trial(s) available for cyclosporine and Keratoconjunctivitis
Article | Year |
---|---|
A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Topics: Administration, Topical; Adolescent; Adult; Child; Conjunctivitis, Allergic; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Japan; Keratoconjunctivitis; Male; Ophthalmic Solutions; Prospective Studies; Severity of Illness Index; Young Adult | 2009 |
Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.
Topics: Adenovirus Infections, Human; Adult; Cyclosporine; Dose-Response Relationship, Drug; Epidemics; Epithelium, Corneal; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Ophthalmic Solutions; Prognosis; Retrospective Studies; Turkey | 2012 |
Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.
Topics: Administration, Topical; Adolescent; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Eosinophil Cationic Protein; Eosinophils; Female; Humans; Immunoglobulin E; Immunosuppressive Agents; Keratoconjunctivitis; Male; Skin Tests | 2006 |
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Treatment Outcome | 2001 |
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Conjunctiva; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Eyelids; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Safety | 2002 |
31 other study(ies) available for cyclosporine and Keratoconjunctivitis
Article | Year |
---|---|
Treating Severe Pediatric Keratoconjunctivitis with Topical Cyclosporine A.
Topics: Administration, Topical; Adult; Child; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Recurrence | 2022 |
Cyclosporine A 1mg/ml in pediatric blepharokeratoconjunctivitis: Case series of 145 children and young people.
Topics: Adolescent; Blepharitis; Child; Cyclosporine; Humans; Immunosuppressive Agents; Keratoconjunctivitis | 2022 |
In Vitro efficacy of cyclosporine a and various antiseptics and antiviral drugs on adenovirus genotype 8, a common cause of epidemic keratoconjunctivitis.
Topics: Adenoviridae; Adenoviridae Infections; Anti-Infective Agents, Local; Antiviral Agents; Chlorhexidine; Cidofovir; Cyclosporine; Ganciclovir; Genotype; Humans; Keratoconjunctivitis; Povidone-Iodine | 2023 |
Cyclosporin A eye drop and subepithelial adenoviral keratoconjunctivitis infiltrates.
Topics: Adenoviridae Infections; Adult; Cyclosporine; Female; Humans; Keratoconjunctivitis; Male; Ophthalmic Solutions; Prospective Studies; Treatment Outcome | 2019 |
Late-term topical tacrolimus for subepithelial infiltrates resistant to topical steroids and ciclosporin secondary to adenoviral keratoconjunctivitis.
Topics: Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eye Infections, Viral; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Ophthalmic Solutions; Tacrolimus; Time Factors; Treatment Outcome | 2021 |
[Keratoconjunctivitis associated with atopic dermatitis treated with tocilizumab].
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Blindness; Cyclosporine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Off-Label Use | 2018 |
Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment.
Topics: Administration, Topical; Adult; Biomarkers; Biopsy; Chronic Disease; Conjunctiva; Conjunctivitis, Allergic; Cornea; Cyclosporine; Female; Follow-Up Studies; HLA-DR Antigens; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Interleukin-33; Keratoconjunctivitis; Male; Middle Aged; Severity of Illness Index; Young Adult | 2019 |
Successful treatment of phlyctenular keratoconjunctivitis with topical cyclosporin A.
Topics: Administration, Ophthalmic; Administration, Topical; Adolescent; Cyclosporine; Epithelium, Corneal; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Treatment Outcome | 2013 |
Topical cyclosporine a 1% for the treatment of chronic ocular surface inflammation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Young Adult | 2014 |
Topical Cyclosporine A 1% for the Treatment of Chronic Follicular Conjunctivitis.
Topics: Administration, Topical; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Visual Acuity | 2015 |
[Adenoviral keratoconjunctivitis].
Topics: Adenoviridae Infections; Cyclosporine; Diagnosis, Differential; Eye Infections, Viral; Humans; Keratoconjunctivitis; Ophthalmic Solutions; Treatment Outcome | 2015 |
Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
Topics: Acute Disease; Adenovirus Infections, Human; Cyclosporine; Eye Infections, Viral; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Lubricant Eye Drops; Male; Ophthalmic Solutions; Prednisolone; Retrospective Studies; Treatment Outcome; Visual Acuity | 2017 |
Long-term topical cyclosporine treatment improves tear production and reduces keratoconjunctivitis in rabbits with induced autoimmune dacryoadenitis.
Topics: Administration, Topical; Animals; Autoimmune Diseases; Cyclosporine; Dacryocystitis; Drug Administration Schedule; Dry Eye Syndromes; Female; Immunosuppressive Agents; Keratoconjunctivitis; Rabbits; T-Lymphocytes; Tears | 2009 |
Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.
Topics: Adult; Alleles; Allopurinol; Anticonvulsants; Asian People; Carbamazepine; China; Cyclosporine; Drug Hypersensitivity; Genetic Predisposition to Disease; Genetic Testing; Gout Suppressants; HLA-B Antigens; Humans; Immunization, Passive; Immunosuppressive Agents; Keratoconjunctivitis; Male; Stevens-Johnson Syndrome; Urethritis | 2010 |
Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
Topics: Adenovirus Infections, Human; Administration, Topical; Cyclosporine; Epithelium, Corneal; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Intraocular Pressure; Keratoconjunctivitis; Male; Middle Aged; Prognosis; Retrospective Studies; Surveys and Questionnaires; Visual Acuity | 2010 |
Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
Topics: Adenoviridae; Adenovirus Infections, Human; Adult; Aged; Aged, 80 and over; Child; Cyclosporine; Epithelium, Corneal; Eye Infections, Viral; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Visual Acuity | 2011 |
Sterile keratitis after corneal collagen crosslinking in a child.
Topics: Child; Collagen; Cyclosporine; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Keratoconus; Male; Photochemotherapy; Riboflavin; Treatment Outcome; Ultraviolet Rays | 2012 |
Oral azithromycin combined with topical anti-inflammatory agents in the treatment of blepharokeratoconjunctivitis in children.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Azithromycin; Blepharitis; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Treatment Outcome; Visual Acuity | 2013 |
Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis.
Topics: Administration, Topical; Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Limbus Corneae; Middle Aged; Prednisolone; Retrospective Studies; Silver Nitrate; Treatment Failure | 2003 |
Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease.
Topics: Animals; Biological Availability; Cyclosporine; Dogs; Drug Evaluation, Preclinical; Drug Implants; Electroretinography; Eye; Female; Graft vs Host Disease; Immunosuppressive Agents; Keratoconjunctivitis; Male; Rabbits; Retina; Safety; Sclera | 2005 |
Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Ophthalmic Solutions; Prospective Studies; Treatment Outcome | 2006 |
Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
Topics: Administration, Topical; Adult; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Limbus Corneae; Middle Aged; Ophthalmic Solutions; Recurrence; Treatment Outcome | 2008 |
Phlyctenular keratoconjunctivitis in a patient with Staphylococcal blepharitis and ocular rosacea.
Topics: Administration, Oral; Administration, Topical; Adult; Aza Compounds; Blepharitis; Cyclosporine; Doxycycline; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratoconjunctivitis; Male; Moxifloxacin; Ophthalmic Solutions; Prednisolone; Quinolines; Rosacea; Staphylococcal Infections | 2008 |
[Cyclosporin A eyedrops for keratitis nummularis after adenovirus keratoconjunctivitis].
Topics: Adenovirus Infections, Human; Chronic Disease; Corneal Opacity; Cyclosporine; Humans; Immunosuppressive Agents; Keratitis; Keratoconjunctivitis; Ophthalmic Solutions | 2008 |
Cyclosporin-responsive keratoconjunctivitis in the cat and horse.
Topics: Administration, Topical; Animals; Cat Diseases; Cats; Chronic Disease; Cyclosporine; Female; Horse Diseases; Horses; Immunosuppressive Agents; Keratoconjunctivitis; Male; Ophthalmic Solutions | 1995 |
Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis.
Topics: Adolescent; Blood Proteins; Cell Count; Child; Cyclosporine; Dexamethasone; Eosinophil Granule Proteins; Eosinophils; Female; Humans; Hypersensitivity; Inflammation Mediators; Keratoconjunctivitis; Male; Reference Values; Ribonucleases; Seasons; Tears | 1995 |
[Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis--case report].
Topics: Adenovirus Infections, Human; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Middle Aged; Ophthalmic Solutions; Recurrence; Treatment Outcome; Visual Acuity | 1997 |
[Ophthalmologic quiz. Enophthalmos and blepharospasm in a dog].
Topics: Animals; Blepharospasm; Cyclosporine; Diagnosis, Differential; Dog Diseases; Dogs; Enophthalmos; Keratoconjunctivitis; Male; Ophthalmic Solutions; Pilocarpine; Prednisolone | 1998 |
[Amniotic membrane transplantation with or without limbal allografts in corneal surface reconstruction in limbal deficiency].
Topics: Amnion; Cell Transplantation; Contact Lenses; Corneal Diseases; Cyclosporine; Epithelium, Corneal; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Limbus Corneae; Postoperative Care; Prospective Studies; Time Factors | 2000 |
[Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study].
Topics: Adult; Aged; Aged, 80 and over; Conjunctivitis, Viral; Corneal Opacity; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Treatment Outcome | 2000 |
[Perforating keratoplasty in endogenous eczema. An indication for systemic cyclosporin A--a retrospective study of 18 patients].
Topics: Adult; Aged; Blepharitis; Cyclosporine; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; Keratoconjunctivitis; Keratoconus; Keratoplasty, Penetrating; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Visual Acuity | 1992 |